SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-041730
Filing Date
2017-08-09
Accepted
2017-08-09 16:45:59
Documents
42
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471795_10q.htm 10-Q 496259
2 EXHIBIT 10.1 v471795_ex10-1.htm EX-10.1 180491
3 EXHIBIT 10.2 v471795_ex10-2.htm EX-10.2 43856
4 EXHIBIT 31.1 v471795_ex31-1.htm EX-31.1 10158
5 EXHIBIT 31.2 v471795_ex31-2.htm EX-31.2 10105
6 EXHIBIT 32.1 v471795_ex32-1.htm EX-32.1 3735
7 EXHIBIT 32.2 v471795_ex32-2.htm EX-32.2 3672
  Complete submission text file 0001144204-17-041730.txt   2858475

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ck0001651407-20170630.xml EX-101.INS 469491
9 XBRL TAXONOMY EXTENSION SCHEMA ck0001651407-20170630.xsd EX-101.SCH 26317
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001651407-20170630_cal.xml EX-101.CAL 18797
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001651407-20170630_def.xml EX-101.DEF 182500
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001651407-20170630_lab.xml EX-101.LAB 189742
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001651407-20170630_pre.xml EX-101.PRE 204882
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 171018531
SIC: 2834 Pharmaceutical Preparations